Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Anacor: Overvalued On Weak Drug Pipeline
Anacor: Overvalued On Weak Drug Pipeline
Anacor: Overvalued On Weak Drug Pipeline
Submitted by
admin
on August 20, 2013 - 10:25am
Source:
TheStreet.com
News Tags:
Anacor
Valeant Pharmaceuticals
AN2728
Tavaborole
Headline:
Anacor: Overvalued On Weak Drug Pipeline
Do Not Allow Advertisers to Use My Personal information
